Sir Jonathan Symonds CBE

Sir Jonathan Symonds was appointed as Chair to the GSK Board on 1 September 2019. He has extensive international financial, life sciences and governance experience.

Jon served as an Independent Non-Executive Director of HSBC Holdings plc from April 2014, and as Deputy Group Chairman from August 2018, until his retirement from the Board in February 2020.

---

He was previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner at KPMG.

His governance experience includes roles as Non-Executive Director and Chair of the Audit Committees of Diageo plc and QinetiQ Group plc and Non-Executive Chair of Proteus Digital Health Inc.

Jon is a Non-Executive director of Rubius Therapectics, Inc; Non-Executive Director of Genomics England Limited, having previously served as its Chairman, and a Member of the European Round Table for Industry.